Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    The MAHA Trend in Groceries Will Backfire

    24. August 2025

    Many college students turn to ChatGPT for therapy. Is that OK?

    24. August 2025

    WHO declares Kenya free of deadly sleeping sickness after decades

    24. August 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Dexcom recalls more than 2 million CGM receivers for lack of audible alarm
    News

    Dexcom recalls more than 2 million CGM receivers for lack of audible alarm

    HealthradarBy Healthradar18. Juni 2025Keine Kommentare3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Dexcom recalls more than 2 million CGM receivers for lack of audible alarm
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Dive Brief:

    • A problem with Dexcom’s receivers for its glucose sensors may cause people to not get an audible alert for low or high blood sugar levels, the Food and Drug Administration said in an enforcement report posted Monday. More than 2 million devices are affected by the Class I recall, the highest risk category.
    • The receiver, a handheld device that gives glucose readings, may not provide an audible alert due to a manufacturing problem. Dexcom said in a letter to customers that, as of May, it had received 56 reports of severe adverse events, such as seizure, loss of consciousness, and other hypoglycemic or hyperglycemic symptoms. All of the people recovered, the company said.
    • The recall applies to receivers associated with Dexcom’s G7, G6, One and One+ CGMs. Dexcom is asking users to return the affected devices and is offering replacements.

    Dive Insight:

    Dexcom started the recall on May 12. For the G7, more than 1.9 million receivers were affected globally, while for the G6, more than 182,000 devices were affected. Tens of thousands of receivers were recalled for Dexcom’s One and One+ CGMs. 

    At the end of 2024, Dexcom had about 2.8 million to 2.9 million users globally, according to the company’s annual report.

    The manufacturing problem involves defective foam or an assembly error that may cause the receiver’s speaker to lose contact with the printed circuit board, according to entries posted in the FDA’s recall database. The affected devices will still provide hypoglycemia or hyperglycemia alerts through other cues, such as vibration and visual prompts, according to the database entry.  

    The recall does not affect people who use Dexcom’s mobile apps to display glucose values and for alerts and alarms, who make up the majority of the company’s users, Dexcom spokesperson James McIntosh wrote in an email. For the affected receivers that have been distributed, the reported incidence rate is .015%, according to the email.

    Dexcom said in the June 3 letter to customers that it had received 112 complaints associated with the malfunction. 

    Dexcom is asking users to check if their receiver is affected and contact technical support to coordinate a return and receive a free replacement. The company also recommended regular testing of the speaker, regardless of whether a receiver is affected by the recall. 

    Earlier this year, Dexcom issued a Class II recall that said in rare situations, the Dexcom G6 touchscreen receiver may not provide high or low glucose alerts. At the time, Dexcom told users to check CGM glucose values regularly and to turn the receiver off and on.



    Source link

    alarm audible CGM Dexcom Lack million recalls receivers
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleCannabis Use Raises Risk of Cardiovascular Disease, Stroke, and Death
    Next Article HIV protection with just two shots a year: FDA approves Gilead drug
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    Charlie Health Expands Virtual Behavioral Healthcare to Ages 8-64

    23. August 2025
    News

    Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

    22. August 2025
    News

    The robotic surgery market battle is heating up

    22. August 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202540 Views

    Linea Expands AI-Powered Heart Failure Care Solution

    6. August 202518 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202517 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20259 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202540 Views

    Linea Expands AI-Powered Heart Failure Care Solution

    6. August 202518 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.